Translate

Dengue Fever Global Clinical Trials Review, H2, 2017

"Dengue Fever Global Clinical Trials Review, H2, 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

- Summary

GlobalData's clinical trial report, Dengue Fever Global Clinical Trials Review, H2, 2017" provides an overview of Dengue Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.


The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

** Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

** Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

- Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Dengue Fever to Infectious Disease Clinical Trials 14
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Dengue Fever to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Dengue Fever Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Source 105

List of Tables
Dengue Fever Therapeutics, Global, Clinical Trials by Region, 2017* 7
Dengue Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Dengue Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Dengue Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Dengue Fever Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Dengue Fever Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 13
Proportion of Dengue Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15
Dengue Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Dengue Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19
Dengue Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Dengue Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Dengue Fever Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Dengue Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Dengue Fever Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Dengue Fever Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Dengue Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Dengue Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
Dengue Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Dengue Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Dengue Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33



Comments

Post a Comment